NASDAQ : TLRY

Tilray Brands, Inc. — Key statistics

Healthcare · Drug Manufacturers - Specialty & Generic · Canada

Last price 2.53 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 371.06M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Key statistics

Valuation

Measure	Value
Market Cap	373.99M
Enterprise Value	527.91M

Dates

Measure	Value
Earnings Date	Oct 8, 2026
Ex-Dividend Date	n/a

Shares

Measure	Value
Current Share Class	146.66M
Shares Outstanding	146.66M
Shares Change (YoY)	+26.70%
Shares Change (QoQ)	+15.43%
Owned by Insiders (%)	1.57%
Owned by Institutions (%)	8.49%
Float	144.37M

Ratios

Measure	Value
PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.39
Forward PS	0.33
PB Ratio	0.22
P/TBV Ratio	0.45
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Evratios

Measure	Value
EV / Earnings	n/a
EV / Sales	0.55
EV / EBITDA	41.60
EV / EBIT	n/a
EV / FCF	n/a

Financialposition

Measure	Value
Current Ratio	1.88
Quick Ratio	0.95
Debt / Equity	0.23
Debt / EBITDA	19.56
Debt / FCF	n/a
Interest Coverage	-2.02

Financialefficiency

Measure	Value
Return on Equity (ROE)	-9.38%
Return on Assets (ROA)	-1.64%
Return on Invested Capital (ROIC)	-3.29%
Return on Capital Employed (ROCE)	-3.06%
Weighted Average Cost of Capital (WACC)	10.45%
Revenue Per Employee	$267,900
Profits Per Employee	-$45,679
Employee Count	3,595
Asset Turnover	0.44
Inventory Turnover	2.22

Taxes

Measure	Value
Income Tax	21.11M
Effective Tax Rate	n/a

Stockprice

Measure	Value
Beta (5Y)	1.92
52-Week Price Change	-80.97%
50-Day Moving Average	3.74
200-Day Moving Average	5.44
Relative Strength Index (RSI)	19.88
Average Volume (20 Days)	4,366,245

Shortselling

Measure	Value
Short Interest	21.52M
Short Previous Month	18.79M
Short % of Shares Out	14.67%
Short % of Float	14.91%
Short Ratio (days to cover)	5.15

Incomestatement

Measure	Value
Revenue	963.10M
Gross Profit	282.63M
Operating Income	-57.99M
Pretax Income	-125.59M
Net Income	-164.22M
EBITDA	12.69M
EBIT	-57.99M
Loss Per Share	-$1.38

Balancesheet

Measure	Value
Cash & Cash Equivalents	218.01M
Total Debt	371.93M
Net Cash	-153.92M
Net Cash Per Share	-$1.05
Equity (Book Value)	1.61B
Book Value Per Share	11.29
Working Capital	376.90M

Cashflow

Measure	Value
Operating Cash Flow	-84.34M
Capital Expenditures	-34.47M
Depreciation & Amortization	70.68M
Net Borrowing	-34.92M
Free Cash Flow	-118.82M
FCF Per Share	-$0.81

Margins

Measure	Value
Gross Margin	29.35%
Operating Margin	-6.02%
Pretax Margin	-13.04%
Profit Margin	-17.05%
EBITDA Margin	1.32%
EBIT Margin	-6.02%
FCF Margin	n/a

Dividends

Measure	Value
Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
FCF Payout Ratio	n/a
Buyback Yield	-26.70%
Shareholder Yield	-26.70%
Earnings Yield	-54.28%
FCF Yield	-31.77%

Analystforecasts

Measure	Value
Price Target	$5.72
Price Target Difference	124.39%
Analyst Consensus	Buy
Analyst Count	10
Revenue Growth Forecast (3Y)	8.91%
EPS Growth Forecast (3Y)	58.74%

Stocksplits

Measure	Value
Last Split Date	Dec 2, 2025
Split Type	Reverse
Split Ratio	1:10

Scores

Measure	Value
Altman Z-Score	-1.69
Piotroski F-Score	4

Fairvalue

Measure	Value
Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a